IGF-1R antibody and its use for the diagnosis of cancer
US10457734B2 · kind B2 · utility
1Cited by
0References
24Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 27, 2016 |
| Grant date | Oct 29, 2019 |
| Priority date | — |
| Expiry date | May 4, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to a novel antibody, in particular a monoclonal antibody, capable of binding to IGF-1R, as well as the amino and nucleic acid sequences coding for said antibody.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.